Covid, developed tests for diagnosis from the breath
Researchers from Brown University in Providence (USA) have developed a test capable of detecting SARS-CoV-2 virus particles in the breath that could complement or replace
Researchers from Brown University in Providence (USA) have developed a test capable of detecting SARS-CoV-2 virus particles in the breath that could complement or replace
“For further booster doses” of the anti-Covid vaccination “we will take into consideration all the scientific evidence with respect to the decline of immunity, on
(ANSA) – MILAN, DECEMBER 09 – Stock market indices contrasted in Asia and the Pacific after the laboratory tests of Pfizer and BionTech which have
(ANSA) – ROME, DECEMBER 04 – “In opening this edition yesterday, I mentioned some theaters of crisis: in all these scenarios, Italy’s commitment falls within
Reassure parents about the safety and efficacy of vaccines for children and fight fake news. Here are the Faqs developed by the Bambino Gesù Pediatric
(ANSA) – ROME, 02 DEC – The Moderna and Pfizer-BioNTech vaccines both have a very high efficacy, but the former offers a slightly higher protection.
The strong 6.3% recovery achieved by Italy in 2021, with the exit from the main restrictions related to the coronavirus, will gradually decrease in 2022
(ANSA) – MILAN, 01 DEC – DiaSorin confirms the ability of its molecular tests to identify the Sars-cov-2 virus even against the new Omicron variant.
(ANSA) – MILAN, NOVEMBER 30 – The CEO of Moderna, Stéphane Bancel, expects a “substantial decline” in the effectiveness of the current vaccines against the
(ANSA) – ROME, NOV 29 – “The effectiveness of current vaccines against hospitalization and serious illness is destined to remain strong”. This is what Professor